Evidence map›Paper›PMID 27895679›Full record

ArticleJournal of contemporary brachytherapy2016

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy.

Michelle I Echevarria, Arash O Naghavi, Puja S Venkat, Yazan A Abuodeh, Carlos Chevere, Kosj Yamoah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of contemporary brachytherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michelle I EchevarriaRadiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Arash O NaghaviRadiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Puja S VenkatRadiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Yazan A AbuodehRadiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Carlos ChevereRadiation Oncology, Hospital Oncológico, HIMA San Pablo, Caguas, Portorico.
Kosj YamoahRadiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLow-dose-rate (LDR) brachytherapy has been established as an effective and safe treatment option for men with low and intermediate risk prostate cancer. In this retrospective analysis, we sought to study the effect of body mass index (BMI) on post-implant dosimetric quality. MATERIAL AND

methodsAfter institutional approval, records of patients with non-metastatic prostate cancer treated in Puerto Rico with LDR brachytherapy during 2008-2013 were reviewed. All patients were implanted with

resultsOne-hundred and four patients were included in this study, with 53 (51%) patients having a D

conclusionsIn this study we show that BMI is a significant pre-implant predictor of D

Indexed as

BMIlow-dose-rate brachytherapyprostate cancerseeds

Identifiers

PMID27895679
PMCPMC5116453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.